2021 Competing in the Global Drug of Abuse Testing Market: Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 12 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers

February 2021 | 318 pages | ID: 2578BAA5B499EN
Venture Planning Group

Abstracts

This new 318-page report from VPGMarketResearch contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report is available by section, and can be customized to specific information needs and budget.

The report provides test volume and sales forecasts by country and market segment for the following assays:

• Amphetamines
• Antidepressants
• Barbiturates
• Benzodiazepines
• Cannabinoids/Marijuana
• Cocaine
• LSD
• Methadone
• Methaqualone
• Opiates
• Phencyclidine (PCP)
• Propoxphene

During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.

Contains 318 pages and 68 tables